Search in:

Eye and Brain Volume 12, 2020 - Issue

Submit an article Journal homepage

Open access

356

Views

CrossRef citations to date

Altmetric

Review

Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review

Caberry W Yu1 Faculty of Medicine, Queen’s University, Kingston, Canada

https://orcid.org/0000-0003-4287-2328 View further author information

Matthew Yau2 Faculty of Medicine, University of Toronto, Toronto, CanadaView further author information

Natalie Mezey1 Faculty of Medicine, Queen’s University, Kingston, CanadaView further author information

Ishraq Joarder3 Faculty of Science, University of Toronto, Scarborough, Ontario, Canada

https://orcid.org/0000-0002-6611-6490 View further author information

Jonathan A Micieli4 Department of Ophthalmology and Vision Sciences and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Canada;5 Kensington Vision and Research Centre, Toronto, CanadaCorrespondence[email protected]

https://orcid.org/0000-0003-4911-9152 View further author information

Pages 139-167 | Published online: 03 Nov 2020

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (20)

Eveline Daetwyler, Alfred Zippelius, Peter Meyer & Heinz Läubli. (2023) Pembrolizumab-induced optic neuropathy – a case report. Frontiers in Immunology 14.
Crossref

Frédéric Illouz, Claire Briet & Patrice Rodien. (2023) Immune checkpoint inhibitor-related thyroid dysfunction. Annales d'Endocrinologie 84:3, pages 346-350.
Crossref

Andrew R. Carey. (2023) Case Report: Successful treatment of external beam radiation-induced optic papillopathy with intravitreal anti-VEGF. Frontiers in Ophthalmology 3.
Crossref

K. A. Rumiantseva, A. Yu. Polushin, N. Kh. Abduloeva, Ya. B. Skiba & V. M. Moiseenko. (2023) Opsoclonus-myoclonus-ataxia syndrome as a complication of pembrolizumab treatment in an adult patient (a case report and literature review). Epilepsy and paroxysmal conditions 15:1, pages 26-35.
Crossref

Nabil E. Omar, Hebatalla M. Afifi, Arwa O. Sahal, Rana Mekkawi & Hazem Elewa. 2023. Immune Checkpoint Inhibitors - New Insights and Recent Progress. Immune Checkpoint Inhibitors - New Insights and Recent Progress.

Roxana Teodorescu, Henry Liu & Alfredo A. Sadun. (2023) Pembrolizumab-Associated Optic Neuritis With an Unusual Manifestation of Monocular Optic Disc Edema. Journal of Neuro-Ophthalmology Publish Ahead of Print.
Crossref

Shigeki Hirano, Akira Kojima, Yoko Nakayama, Takahiro Takeda, Takashi Kishimoto, Toshiyuki Takahashi, Satoshi Kuwabara & Masahiro Mori. (2022) A case report of neuromyelitis optica spectrum disorder induced by pembrolizumab treatment for lung adenocarcinoma: a clinical and immunohistochemical study. BMC Neurology 22:1.
Crossref

Eystein S Husebye, Frederik Castinetti, Sherwin Criseno, Giuseppe Curigliano, Brigitte Decallonne, Maria Fleseriu, Claire E Higham, Isabella Lupi, Stavroula A Paschou, Miklos Toth, Monique van der Kooij & Olaf M Dekkers. (2022) Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline. European Journal of Endocrinology 187:6, pages G1-G21.
Crossref

Kimberly M. Winges & Lynn K. Gordon. (2022) Neuro-ophthalmic complications of immune checkpoint inhibitor therapy: Current status and future directions. Frontiers in Ophthalmology 2.
Crossref

Didem Saygin, Nilasha Ghosh & Pankti Reid. (2022) Immune Checkpoint Inhibitor–Associated Myositis. JCR: Journal of Clinical Rheumatology 28:7, pages 367-373.
Crossref

Florence Chaudot, Pascal Sève, Antoine Rousseau, Alexandre Thibault Jacques Maria, Pierre Fournie, Pierre Lozach, Jeremy Keraen, Marion Servant, Romain Muller, Baptiste Gramont, Sara Touhami, Habeeb Mahmoud, Pierre-Antoine Quintart, Stéphane Dalle, Olivier Lambotte, Laurent Kodjikian & Yvan Jamilloux. (2022) Ocular Inflammation Induced by Immune Checkpoint Inhibitors. Journal of Clinical Medicine 11:17, pages 4993.
Crossref

Jibran Mirza, Sunitha Shyam Sunder, Badri Karthikeyan, Sharma Kattel, Saraswati Pokharel, Brian Quigley & Umesh C. Sharma. (2022) Echocardiographic and Cardiac MRI Comparison of Longitudinal Strain and Strain Rate in Cancer Patients Treated with Immune Checkpoint Inhibitors. Journal of Personalized Medicine 12:8, pages 1332.
Crossref

Jian Wang, Xiaoyue Xiao, Xiaorong Dong, Gang Wu, Xinghua Wang & Ruiguang Zhang. (2022) Anti-PD-1 sintilimab-induced bilateral optic neuropathy in non-small cell lung cancer: A case report and literature review. Frontiers in Oncology 12.
Crossref

Jennifer Kizza, Richard J. Lu, Jonah Zuflacht & Marc Bouffard. (2022) Clinical Reasoning: A 48-Year-Old Woman With 6 Months of Vivid Visual Hallucinations. Neurology 99:4, pages 166-171.
Crossref

Alisha Kamboj, Christopher J. Hwang, Collin M. McClelland, Amanda C. Maltry, Andrew R. Harrison & Ali Mokhtarzadeh. (2022) Delayed-Onset Inflammatory Optic Nerve Sheath Mass and Perineuritis Following Cessation of Ipilimumab and Nivolumab Therapy. Ophthalmic Plastic & Reconstructive Surgery 38:4, pages e119-e122.
Crossref

Jacek Baj, Alicja Forma, Joanna Kobak, Magdalena Tyczyńska, Iga Dudek, Amr Maani, Grzegorz Teresiński, Grzegorz Buszewicz, Jacek Januszewski & Jolanta Flieger. (2022) Toxic and Nutritional Optic Neuropathies—An Updated Mini-Review. International Journal of Environmental Research and Public Health 19:5, pages 3092.
Crossref

Saša A Živković & Tawfiq Al-Lahham. (2022) Neurologic Complications of Immune Checkpoint Inhibitors. Neurology 18:1, pages 58.
Crossref

Subahari Raviskanthan, Melissa M. Chu, Peter W. Mortensen, Andrew G. Lee & Nagham Al-Zubidi. 2022. Managing Immunotherapy Related Organ Toxicities. Managing Immunotherapy Related Organ Toxicities 231 253 .

Ana Filipa Palma dos Reis, Ivo Hennig & Andrew Wilcock. (2021) Immune checkpoint inhibitors: current status. BMJ Supportive & Palliative Care, pages bmjspcare-2021-002954.
Crossref

Blake H. Fortes, Prashant D. Tailor & Lauren A. Dalvin. (2021) Ocular Toxicity of Targeted Anticancer Agents. Drugs 81:7, pages 771-823.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review

Articles from other publishers (20)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review

Citations (20)

Articles from other publishers (20)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date